3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
15
Breast Neoplasms
7
Sarcoma
5
Neoplasm Metastasis
4
Carcinoma, Ovarian Epithelial
4
Neoplasms
3
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphadenopathy
1
Interventions
Oxaliplatin
29
Fluorouracil
23
Capecitabine
19
pembrolizumab
18
Nivolumab
17
Leucovorin
16
Docetaxel
10
Trastuzumab
9
Paclitaxel
9
Drug Therapy
9
Cisplatin
9
fludarabine
8
S 1 (combination)
8
Cyclophosphamide
8
Specimen Handling
7
trastuzumab deruxtecan
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
5
Biopsy
5
zolbetuximab
4
Irinotecan
4
Carboplatin
4
zimberelimab
3
sintilimab
3
olaparib
3
fludarabine phosphate
3
durvalumab
3
atezolizumab
3
aldesleukin
3
XELOX
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
liposomal doxorubicin
×
90 days
×
Clear all
No trials found.